Ignite Creation Date:
2024-05-05 @ 7:50 PM
Last Modification Date:
2024-10-26 @ 9:54 AM
Study NCT ID:
NCT00747825
Status:
TERMINATED
Last Update Posted:
2011-10-12
First Post:
2008-09-04
Brief Title:
Phase I Safety and Dosimetry Study in Patients With Confirmed Metastatic Melanoma
Sponsor:
Molecular Insight Pharmaceuticals Inc
Organization:
Molecular Insight Pharmaceuticals Inc